Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02
Published November 13, 2019 · Recall initiated: November 1, 2019
Summary
FDA records drug Class III recall D-0304-2020, published November 13, 2019 and initiated November 1, 2019. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 28,254 bottles; Lot: Lot #: F802436, F802437, F802438, F802442, Exp 11/20. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign substance: identified as a dead ant.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- Product was distributed to major distributors/wholesalers throughout the United States.
- Lot
- Lot #: F802436, F802437, F802438, F802442, Exp 11/20
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClobetasol Propionate Cream USP, 0.05%, 60 g tube, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,September 2, 2026
- FDAGlucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection USP, 1mg per vial, Diluent for Glucagon, 1July 8, 2026
- FDAprednisoLONE Acetate Ophthalmic Suspension, USP, 1%, Rx only, Sterile, a) 5 mL (NDC 70748-332-02); b) 10 mLJuly 8, 2026
- FDALiraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples,May 27, 2026
- FDASankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles,November 13, 2019
- FDACefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals,November 13, 2019
Questions about this recall
Was Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02 recalled?
Yes. FDA published recall D-0304-2020 on November 13, 2019. Reported hazard: Presence of Foreign substance: identified as a dead ant.
What should I do if I have this product?
Voluntary: Firm initiated · Letter